{"count": 2, "results": [{"_id": "27367818", "pmid": 27367818, "title": "Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease.", "journal": "JAMA Intern Med", "authors": ["Dewland TA", "Soliman EZ", "Davis BR", "Magnani JW", "Yamal JM", "Piller LB", "Haywood LJ", "Alonso A", "Albert CM", "Marcus GM", "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group"], "date": "2016-08-01T00:00:00Z", "doi": "10.1001/jamainternmed.2016.2502", "meta_date_publication": "2016 Aug 1", "meta_volume": "176", "meta_issue": "8", "meta_pages": "1085-92", "score": 50074.05, "text_hl": "CONCLUSIONS AND RELEVANCE: Incident @<m>DISEASE_Cardiac_Conduction_System_Disease</m> @DISEASE_MESH:D000075224 @@@conduction system disease@@@ is significantly reduced by @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ therapy and is independently associated with multiple clinical factors. ", "citations": {"NLM": "Dewland TA, Soliman EZ, Davis BR, Magnani JW, Yamal JM, Piller LB, Haywood LJ, Alonso A, Albert CM, Marcus GM, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group. Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease. JAMA Intern Med. 2016 Aug 1;176(8):1085-92. PMID: 27367818", "BibTeX": "@article{27367818, title={Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease.}, author={Dewland TA and Soliman EZ and Davis BR and Magnani JW and Yamal JM and Piller LB and Haywood LJ and Alonso A and Albert CM and Marcus GM and Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group}, journal={JAMA Intern Med}, volume={176}, number={8}, pages={1085-92}}"}}, {"_id": "30676480", "pmid": 30676480, "title": "Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients.", "journal": "J Hypertens", "authors": ["Okin PM", "Kjeldsen SE", "Devereux RB"], "date": "2019-03-01T00:00:00Z", "doi": "10.1097/HJH.0000000000001915", "meta_date_publication": "2019 Mar", "meta_volume": "37", "meta_issue": "3", "meta_pages": "629-635", "score": 50071.547, "text_hl": "BACKGROUND: Previous work has demonstrated that treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with the @GENE_ACE @GENE_1636 @@@angiotensin-converting enzyme@@@ inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ was associated with a reduced incidence of a composite @<m>DISEASE_Cardiac_Conduction_System_Disease</m> @DISEASE_MESH:D000075224 @@@conduction system disease@@@ endpoint and also @DISEASE_Bundle_Branch_Block @DISEASE_MESH:D002037 @@@left bundle branch block@@@ (@DISEASE_Bundle_Branch_Block @DISEASE_MESH:D002037 @@@LBBB@@@) compared with @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@ therapy. ", "citations": {"NLM": "Okin PM, Kjeldsen SE, Devereux RB. Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients. J Hypertens. 2019 Mar;37(3):629-635. PMID: 30676480", "BibTeX": "@article{30676480, title={Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients.}, author={Okin PM and Kjeldsen SE and Devereux RB}, journal={J Hypertens}, volume={37}, number={3}, pages={629-635}}"}}]}